Morgan Stanley raised the firm’s price target on Bayer (BAYRY) to EUR 28 from EUR 26 and keeps an Equal Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bayer says FDA accepts NDA under priority review for sevabertinib
- Bayer price target raised to EUR 25 from EUR 22 at Barclays
- Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
- OTC Markets Group welcomes Bayer to OTCQX
- Trump admin report implies companies are worsening health of children, FT says